Avenue Therapeutics, Inc. · OTC:ATXI
Ikarian Capital, LLC's stake in Avenue Therapeutics, Inc. fell to 4.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ikarian Capital, LLC's stake in Avenue Therapeutics, Inc. fell to 4.10%, 130,820 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 130,820
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 4.10% | 130,820 |
| Neil Shahrestani | 4.10% | 130,820 |
Source
Related
- Avenue Therapeutics, Inc.
- Ikarian Capital, LLC
- Avenue Therapeutics, Inc. shareholders
- Schedule 13G · Ikarian Capital, LLC · Feb 14, 2025
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 6, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Apr 2, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 3, 2025